Company: ABBV
Filing Date: 2025-02-20
Form Type: 424B5
Source: 0001104659-25-015715
Chunk: 17

Company: AbbVie Inc.
Filing Date: 2025-02-20
Form: 424B5
Chunk 17
---

### DESCRIPTION OF NOTES
The Notes will be issued under an indenture, dated as of November 8, 2012 (the “ indenture ”), between AbbVie and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (the “ Trustee ”), as supplemented by one or more supplemental indentures relating to the Notes. The following description of the terms of the Notes supplements, and, to the extent it is inconsistent therewith replaces, the description of the general terms of debt securities set forth in the accompanying prospectus, to which description reference is hereby made. The following summary of certain provisions of the indenture and the Notes does not purport to be complete and is subject to, and is qualified in its entirety by reference to, all the provisions of the indenture and the Notes, including the definitions of certain terms therein and those terms made part thereof by the Trust Indenture Act of 1939 (the “ Trust Indenture Act ”), as amended. In this description all references to “AbbVie,” “we,” “our” and “us” mean AbbVie Inc. only.

#### General
AbbVie is issuing $1,250,000,000 aggregate principal amount of 2028 Notes. The 2028 Notes will mature on March 15, 2028. Interest on the 2028 Notes will accrue at the rate of 4.650% per annum.

AbbVie is issuing $1,000,000,000 aggregate principal amount of 2030 Notes. The 2030 Notes will mature on March 15, 2030. Interest on the 2030 Notes will accrue at the rate of 4.875% per annum.

AbbVie is issuing $1,000,000,000 aggregate principal amount of 2035 Notes. The 2035 Notes will mature on March 15, 2035. Interest on the 2035 Notes will accrue at the rate of 5.200% per annum.

AbbVie is issuing $750,000,000 aggregate principal amount of 2055 Notes. The 2055 Notes will mature on March 15, 2055. Interest on the 2055 Notes will accrue at the rate of 5.600% per annum.

The Notes will be issued in fully registered form and shall be in denominations of $2,000 and integral multiples of $1,000 in excess